Fundraising FoxTibaray
Fremont, US · Delaware corporation · 1 known investors
Find your way into Tibaray
Sign up to see every warm intro you have to Tibaray
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tibaray team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TibaRay develops the Galactica linear accelerator platform for radiotherapy, aimed at enabling faster, more precise FLASH cancer treatment. The company integrates its linac technology with upright patient positioning systems and also applies its accelerator platform to imaging and RF applications for government customers.
Founders & leadership
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 round · 2025
▶$1.3MraisedMay 2025 · 10 investors · Other TechnologyRule 506(b)
- Laird Q. CaganDirector
- Sami TantawaiDirector
- Cecilia Carol MontalvoExecutive Officer, Director
- Bill LooDirector
- James VetterDirector
- Peter MaximDirector
- Offering amount
- $5M
- Amount sold
- $1.3M
- Proceeds to insiders
- $500K
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 14 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Energy | Phase II | 2023 | $1.1M |
| Department of Energy | Phase II | 2022 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $399.6K |
| Department of Energy | Phase I | 2022 | $199.8K |
| Department of Energy | Phase I | 2021 | $200K |
| Department of Energy | Phase II | 2020 | $1M |
| Department of Energy | Phase I | 2020 | $200K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $2M |
| Department of Energy | Phase I | 2019 | $149.4K |
| Department of Energy | Phase II | 2018 | $1M |
| Department of Energy | Phase II | 2018 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $224.7K |
| Department of Energy | Phase I | 2017 | $149.2K |
| Department of Energy | Phase I | 2017 | $148.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Tibaray do?
- TibaRay develops the Galactica linear accelerator platform for radiotherapy, aimed at enabling faster, more precise FLASH cancer treatment. The company integrates its linac technology with upright patient positioning systems and also applies its accelerator platform to imaging and RF applications for government customers.
- Who are Tibaray's investors?
- Tibaray's investors include StartX.
- How much funding has Tibaray raised?
- Tibaray has disclosed $1.3M raised across 1 round.
- Where is Tibaray headquartered?
- Tibaray is headquartered in Fremont, US.